We have attempted to identify the covalent structure of the M protein molecue of group A streptococci that is responsible for inducing type-specific, protective immunity. M protein was extracted from type 24 streptococci, purified, and cleaved with cyanogen bromide. Seven cyanogen bromide peptides were purified and further characterized. Together, the peptides account for the entire amino acid content of the M protein molecule. Each of the purified peptides possessed the type-specific determinant that inhibits opsonic antibodies for group A streptococci. The primary structures of the aminoterminal regions of each of the purified peptides was studied by automated Edman degradation. The partial sequences of two of the peptides were found to be identical to each other and to that ofthe uncleaved M protein molecule through at least the first 27 residues. The amino-terminal sequences of the remaining five peptides were identical to each other through the twentieth residue but completely different from the aminoterminal region of the other two peptides. However, the typespecific immunoreactivity and the incomplete analysis of the primary structure of the seven peptides suggest that the antiphagocytic determinant resides in a repeating amino acid sequence in the M protein molecule. The opsonic and presumably protective antibodies against group A streptococci are directed exclusively against the type-specific M protein antigen located on the surface of virulent organisms. Attempts to immunize humans against streptococcal infections have been hampered by toxic reactions to vaccines prepared from almost any streptococcal product, including various M protein preparations (1). Crossreactive toxic moieties are often closely associated with the M protein molecule; the conventional methods of extraction and purification have failed to consistently separate the M protein from these moieties, which account for toxic reactions in the skin (2-5) and in the blood (6, 7).Several years ago Cunningham and Beachey (8) showed that limited peptic digestion abolished the toxic properties while retaining type-specific immunogenicity of purified preparations of M protein. Subsequently, M protein was extracted directly from group A streptococci by subjecting the intact organisms to limited digestion with pepsin (9). The peptic extracts of M protein (pep M) were then purified to homogeneity, and the antigen was readily separable from crossreactive toxic materials (10). In its purified form the M antigen was immunogenic in laboratory animals, producing high titers of typespecific opsonic antibodies without producing crossreactive antibodies against M-associated antigens (10, 11). Furthermore, the purified antigen was well tolerated in skin tests of guinea pigs and humans (11,12).Having obtained satisfactory yields of purified pep M protein, we thought it of interest to study the primary structure ofThe costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marke...